POC Diagnostics, Global Health-Viral Diseases 2017
Point-of-Care Diagnostics, Global Health & Emerging Viral Diseases World Congress 2017
Date: October 2 - 4, 2017
Venue: Coronado Island Marriott Resort & Spa, Coronado Island, California USA

Keynote Speakers

Kamlesh Patel

Kamlesh Patel
R&D Advanced System Engineering and Deployment Manager, Sandia National Laboratories

Alexis Sauer-Budge

Alexis Sauer-Budge
Senior Research Scientist and Adjunct Research Assistant Professor, Boston University and Fraunhofer Center for Manufacturing Innovation (CMI)

Marya Lieberman

Marya Lieberman
Professor, University of Notre Dame

Chamindie Punyadeera

Chamindie Punyadeera
Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology

Charles Henry

Charles Henry
Professor and Chair, Colorado State University

Ellen Jo Baron

Ellen Jo Baron
Executive Director, Medical Affairs, Cepheid

Bernhard Weigl

Bernhard Weigl
Principal Investigator, Flow Based Diagnostics, Intellectual Ventures/Global Good, University of Washington

John Brennan

John Brennan
Professor and Director, Biointerfaces Institute, McMaster University

David Wong

David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

John T McDevitt

John T McDevitt
Chair, Department of Biomaterials, New York University College of Dentistry Bioengineering Institute

Michael Heller

Michael Heller
Professor, University of California San Diego


Welcome to the Select Biosciences, Inc. 5th Annual Point-of-Care Diagnostics, Global Health and Emerging Viral Diseases World Congress 2017.

This annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and bring in the Emerging Viral Diseases field providing the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval.  Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.

This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents approximately 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.

Registered conference delegates have access to the co-located parallel conferences:
  • Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2017
  • Lab-on-a-Chip and Microfluidics: Techologies and Commercialization 2017
  • Point-of-Care Diagnostics Global Health and Emerging Viral Diseases World Congress2017
  • Biosecurity and Biosensors Summit 2017

The Exhibit Hall is Co-Located with the Conference Tracks and is open October 2-4, 2017.

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 25 September 2017

Agenda Topics

  • Global Health and Emerging Viral Diseases such as Ebola and Zika
  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
    • Emerging Technologies and Emerging Companies Showcase
    • Low-Cost POC Devices for Deployment Worldwide
    • POC Diagnostics in Resource-Limited Settings
  • POC Diagnostics for Global Health: A Worldwide Perspective
  • POC Diagnostics in Cancer and Oncology Testing
  • POC Diagnostics in Cardiovascular Disease Testing
  • POC Diagnostics in Infectious Disease Testing
  • Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing for Global Health

Confirmed Speakers to date

Gavi Begtrup, Chief Technology Officer, Eccrine Systems, Inc.
Jane Brock, Assistant Professor, Brigham And Women's Hospital/Harvard Medical School
Gene Dantsker, Director, Business Development, Qualcomm LIFE, Inc.
Joany Jackman, Senior Scientist, Research and Exploratory Development, The Johns Hopkins University Applied Physics Laboratory
Changchun Liu, Research Assistant Professor, University of Pennsylvania
Xianqiang Mi, Medical Device Advisor, Chinese Academy Of Sciences
Barbara Smith, Assistant Professor, Arizona State University

Exhibition Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Traditional Chinese
Simplified Chinese